Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Clin Exp Immunol1
Search Results
Sort by
- Bookedited by Ipek Kurtböke.Contents:
Planctomycetes : new models for microbial cells and activities / John A. Fuerst
A flavor of prokaryotic taxonomy : systematics revisited / Paul De Vos, Fabiano Thompson, Cristiane Thompson and Jean Swings
Bioactive actinomycetes : reaching rarity through sound understanding of selective culture and molecular diversity / Ipek Kurböke
Microbial resources for global sustainability / Jim Philp and Ronald Atlas
Modern natural products drug discovery and its relevance to biodiversity conservation / C. Benjamin Naman, Christopher A. Leber and William H. Gerwick
Hydrocarbon-oxidizing bacteria and their potential in eco-biotechnology and bioremediation / Irena B. Ivshina, Maria S. Kuyukina and Anastasiya V. Krivoruchko
An overview of the industrial aspects of antibiotic discovery / Evan Martens and Arnold L. Demain
Accessing marine microbial diversity for drug discovery/ Lynette Bueno Pérez and William Fenical
Cryptic pathways and implications for novel drug discovery / Kozo Ochi
The Nagoya protocol applied to microbial genetic resources / Philippe Desmeth
Fungal genetic resources for biotechnology / Kevin McCluskey
Industrial culture collections : gateways from microbial diversity to applications / Olga Genilloud
An overview of biological resource center-maintenance of microbial resources and their management / Ken-ichiro Suzuki
IP and the Budapest Treaty : depositing biological material for patent purposes / Vera Bussas, Avinash Sharma and Yogesh Shouche
Biosafety, transport, and related legislation concerning microbial resources : an overview / Vera Bussas.Digital Access ScienceDirect 2017 - ArticleGolenser J, Heeren J, Verhave JP, Kaay HJ, Meuwissen JH.Clin Exp Immunol. 1977 Jul;29(1):43-51.IFA studies are reported using plasmodial antigens from three different stages of the life cycle of Plasmodium berghei: sporozoites (SP); exoerythrocytic schizonts in rat liver (EEF); and parasitized rat erythrocytes (SCH = schizonts). Two series of specific sera were applied: sera from adult rats with a blood-induced infection (series A) and sera from rats immunized against sporozoites by mosquito bites and protected against parasitaemia by chloroquine (series B). In series A antibody titres with all three antigens were seen, but those with SCH were generally the highest. Superinfection with parasitized rat blood did not change the titre. In series B sera, collected from rats after a single exposure to infected mosquitoes, showed only titres with SP from day 3 onwards, but after a second exposure titres to all three antigens developed. Crossreactivity with the heterologous antigens in series B was clearly less than in series A. Anti-P. berghei sporozoite antibodies did not crossreact with P. vivax sporozoites. Rats of series A were resistant to a challenge of parasitized blood and could also inhibit the development of sporozoites. Rats of series B were protected against a challenge of sporozoites but not of infected blood. The results are discussed.